Envara Health is a GI-focused company bringing breakthrough science, clinical evidence, and meaningful health improvements to the field of clinical nutrition. The company is led by a team of experienced life science and clinical nutrition executives committed to addressing the widespread problem of malabsorption, unintentional weight loss and resulting poorer health outcomes.
Our validated structured lipid platform will enable the development of a suite of precision nutrient products that will address a broad spectrum of disease states in both humans and animals. Our first product, Encala®, is a medical food that provides a source of needed, healthy calories, including the essential fatty acids, in an easily absorbable structure.
At Envara Health, we pride ourselves in our ability to make significant advancements in clinical nutrition through commitment, innovation, and evidence-based research. We live by our values centered on quick problem-solving, curious learning, straight-talk, and accountability to pursue our vision to elevate nutrition to help humanity thrive.
Envara Health, Inc. is committed to making significant advancements in the field of clinical nutrition. Our goal is to provide clinically proven, medically innovative products that enable better outcomes for the people we serve. Founded in 2017 by Dr. Virginia Stallings, MD and Jim O’Connell, Envara Health has assembled a team of highly successful life science industry veterans with extensive commercialization and manufacturing experience to lead the company’s first product launch of Encala. Invented by the late Dr. David Yesair, PhD, an internationally recognized biochemist, and patented under the original registered trademark, Lym-X-Sorb, Encala was inspired by and developed for patients with cystic fibrosis who struggle with malabsorption.